Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis.

Albini, A; Florio, T; Giunciuglio, D; Masiello, L; Carlone, S; Corsaro, A; Thellung, S; Cai, T; Noonan, D M; Schettini, G

Albini, A; Florio, T; Giunciuglio, D; Masiello, L; Carlone, S; Corsaro, A; Thellung, S; Cai, T; Noonan, D M; Schettini, G.

Affiliation

Albini A; Modulo Progressione Neoplastica, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. albini@ermes.cba.uniga.it

FASEB J ; 13(6): 647-55, 1999 Apr.

Article in En | MEDLINE | ID: mdl-10094925

Subject(s)

Neovascularization, Pathologic/drug therapy; Sarcoma, Kaposi/drug therapy; Somatostatin/therapeutic use; Animals; Cell Line; Cell Polarity/drug effects; Chemotaxis, Leukocyte; Endothelium, Vascular/cytology; Endothelium, Vascular/drug effects; Humans; Mice; Mice, Nude; Monocytes/drug effects; Monocytes/physiology; Receptors, Somatostatin/analysis; Sarcoma, Kaposi/blood supply

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / Somatostatin / Neovascularization, Pathologic Type of study: Guideline Limits: Animals / Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 1999 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links